HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angel Chao Selected Research

Angel Chao Research Topics

Disease

43Neoplasms (Cancer)
02/2022 - 08/2002
22Endometrial Neoplasms (Endometrial Cancer)
02/2022 - 01/2006
14Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2018 - 04/2004
10Carcinoma (Carcinomatosis)
11/2021 - 07/2004
10Ovarian Neoplasms (Ovarian Cancer)
07/2021 - 09/2010
7Endometriosis
11/2021 - 11/2008
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2021 - 05/2009
5Neoplasm Metastasis (Metastasis)
11/2021 - 09/2007
4Uterine Cervical Dysplasia
07/2012 - 04/2004
3Carcinogenesis
01/2021 - 02/2013
3Cicatrix (Scar)
01/2018 - 07/2005
3Infections
01/2012 - 07/2009
3Fever (Fevers)
10/2009 - 08/2002
2Lymphatic Metastasis
11/2021 - 11/2010
2Disease Progression
07/2021 - 12/2014
2Myoma
07/2020 - 01/2018
2Adenomyosis
04/2018 - 01/2018
2Uterine Hemorrhage (Uterine Bleeding)
02/2011 - 07/2005
2Choriocarcinoma
05/2010 - 08/2002
2Abscess
07/2009 - 08/2002
1Hyperplasia
02/2022
1Endometrial Hyperplasia
02/2022
1Leiomyoma (Uterine Fibroids)
01/2022
1Carcinosarcoma
11/2021
1Neoplasm Micrometastasis
10/2021
1Papillomavirus Infections
01/2021

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
09/2021 - 07/2009
10PhosphoproteinsIBA
03/2021 - 09/2010
9DNA (Deoxyribonucleic Acid)IBA
01/2015 - 04/2004
6Biomarkers (Surrogate Marker)IBA
02/2022 - 09/2010
5RNA (Ribonucleic Acid)IBA
11/2021 - 07/2006
5Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2018 - 10/2004
4Estrogens (Estrogen)FDA Link
09/2016 - 01/2012
3MicroRNAs (MicroRNA)IBA
02/2022 - 05/2010
3AntigensIBA
11/2021 - 06/2013
3NucleophosminIBA
01/2021 - 02/2013
3Estrogen ReceptorsIBA
07/2019 - 01/2013
3Formaldehyde (Formol)FDA Link
12/2016 - 05/2010
3ParaffinIBA
12/2016 - 05/2010
3Phosphotransferases (Kinase)IBA
09/2014 - 08/2012
3Tumor Biomarkers (Tumor Markers)IBA
06/2013 - 10/2004
3squamous cell carcinoma-related antigenIBA
11/2010 - 07/2004
3Anti-Bacterial Agents (Antibiotics)IBA
10/2009 - 08/2002
2palbociclibIBA
11/2021 - 07/2019
2Lysine (L-Lysine)FDA Link
03/2021 - 09/2017
2AntibodiesIBA
03/2021 - 01/2013
2LuciferasesIBA
03/2021 - 04/2018
2Peptides (Polypeptides)IBA
03/2021 - 08/2016
2Biological ProductsIBA
01/2021 - 07/2009
2VaccinesIBA
01/2021 - 02/2011
2Pharmaceutical PreparationsIBA
01/2020 - 02/2016
2Tyrosine Kinase InhibitorsIBA
01/2020 - 09/2014
2Acetates (Acetic Acid Esters)FDA Link
07/2019 - 09/2016
2PlatinumIBA
01/2018 - 02/2016
2Cisplatin (Platino)FDA LinkGeneric
06/2017 - 02/2016
2LipidsIBA
01/2017 - 07/2009
2Hormones (Hormone)IBA
09/2016 - 02/2013
2Heat-Shock Proteins (Heat-Shock Protein)IBA
08/2016 - 08/2012
2activin receptor type II-A (activin A receptor, type II)IBA
01/2013 - 08/2012
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2022
1lenvatinibIBA
11/2021
1InterferonsIBA
11/2021
1Glucose (Dextrose)FDA LinkGeneric
11/2021
1Therapeutic UsesIBA
11/2021
1Protein Isoforms (Isoforms)IBA
11/2021
1alpha 1-Antitrypsin (alpha 1 Antitrypsin)IBA
11/2021
1Inhibitor of Apoptosis ProteinsIBA
10/2021
1LCL161IBA
10/2021
1Topotecan (Hycamtin)FDA LinkGeneric
10/2021
1Choline (Choline Chloride)IBA
10/2021
1Keratins (Keratin)IBA
10/2021
1Hematoxylin (Haematoxylon)IBA
10/2021
1Eosine Yellowish-(YS) (Eosin)IBA
10/2021
1Combined Antibody TherapeuticsIBA
10/2021
1Bevacizumab (Avastin)FDA Link
07/2021
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
04/2021
1Janus Kinase 2IBA
03/2021
1CaspasesIBA
03/2021
1HEPESIBA
03/2021
1Transcription Factors (Transcription Factor)IBA
01/2021
1Glycogen Synthase (Synthase I)IBA
01/2021

Therapy/Procedure

12Therapeutics
11/2021 - 09/2007
9Drug Therapy (Chemotherapy)
11/2021 - 08/2002
6Hysterectomy
08/2018 - 08/2002
5Salvage Therapy
06/2014 - 07/2004
4Adjuvant Chemotherapy
11/2021 - 10/2016
4Aftercare (After-Treatment)
04/2020 - 02/2007
4Chemoradiotherapy
01/2018 - 09/2016
3Uterine Myomectomy
01/2022 - 01/2018
3Radiotherapy
03/2014 - 11/2010
2Cytoreduction Surgical Procedures
07/2021 - 01/2018
2Neoadjuvant Therapy
07/2021 - 06/2017
2Laparotomy
04/2021 - 11/2008
2Length of Stay
01/2018 - 10/2009
2Cesarean Section (Caesarean Section)
03/2013 - 02/2011
2Conservative Treatment
03/2011 - 10/2010
2Cystectomy
10/2010 - 11/2008
1Uterine Artery Embolization
01/2022
1Lymph Node Excision (Lymph Node Dissection)
03/2021
1Immunotherapy
01/2021